Technical Articles

揭秘Siglec-2:癌症治疗领域的新型免疫检查点
Unveiling Siglec-2: A New Immune Checkpoint in the Field of Cancer Treatment
发布时间 2025-08-28
Siglec-2 (also known as CD22) is a member of the sialic acid binding immunoglobulin like lectin (Siglec) receptor family, primarily expressed on the surface of B cells. As an inhibitory receptor, it regulates immune response by recognizing sialylated polysaccharides on the cell surface.
View details
  • Cancer
  • Siglec-2
  • Cancer
  • immunity
Siglec-2(CD22):B 细胞免疫调控与疾病靶向治疗的研究进展
Siglec-2 (CD22): Research progress on B cell immune regulation and disease targeted therapy
发布时间 2025-07-30
Siglec-2 (also known as CD22) is a highly conserved member of the sialic acid recognizing immunoglobulin like lectin (Siglec) family, mainly expressed on the surface of B lymphocytes. It participates in the precise regulation of B cell activation, proliferation, and tolerance by recognizing sialic acid modified sugar chain structures.
View details
  • Immunity/Inflamma
  • Siglec-2
Total 2
  • 1
Go to